Langenbeck's archives of surgery · 2008
Renal transplantation today.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Neipp Michael, Jackobs Steffan, Klempnauer Jürgen
Аннотация
BACKGROUND: The first successful renal transplant was carried out more than five decades ago between identical twins. At these early days, acute rejection was the limiting factor.
DISCUSSION: Due to tremendous progress in immunosuppressive therapy and surgical technique, today, renal transplantation is the gold standard therapy for patients with end-stage renal disease. In fact, in comparison with chronic hemodialysis, renal transplantation offers an increase in quality of life while reducing comorbidities associated with dialysis treatment.
RESULTS: Despite numerous beneficial achievements, no further improvement regarding patient outcome can be observed over the last two decades. Graft survival rates remain unchanged. The leading causes for graft loss are chronic allograft nephropathy and death with functioning graft. This might be related to a constant increase of the proportion of donors presenting extended donor criteria as well as a more liberal acceptance of candidates for a renal transplant.
CONCLUSION: In the near future, one has to focus more closely on the posttransplant patient care to minimize factors associated with chronic allograft damage. These include post-transplant diabetes, hyperlipidemia, high blood pressure, cytomegalovirus infection, etc.
DISCUSSION: Due to tremendous progress in immunosuppressive therapy and surgical technique, today, renal transplantation is the gold standard therapy for patients with end-stage renal disease. In fact, in comparison with chronic hemodialysis, renal transplantation offers an increase in quality of life while reducing comorbidities associated with dialysis treatment.
RESULTS: Despite numerous beneficial achievements, no further improvement regarding patient outcome can be observed over the last two decades. Graft survival rates remain unchanged. The leading causes for graft loss are chronic allograft nephropathy and death with functioning graft. This might be related to a constant increase of the proportion of donors presenting extended donor criteria as well as a more liberal acceptance of candidates for a renal transplant.
CONCLUSION: In the near future, one has to focus more closely on the posttransplant patient care to minimize factors associated with chronic allograft damage. These include post-transplant diabetes, hyperlipidemia, high blood pressure, cytomegalovirus infection, etc.
Предметные рубрики MeSH
AdolescentAdultAgedChildChild, PreschoolForecastingGermanyGraft RejectionGraft SurvivalHealth Services Needs and DemandHumansImmunosuppression TherapyInfantKidney Failure, ChronicKidney TransplantationLiving DonorsMicrosurgeryMiddle AgedPopulation DynamicsPostoperative ComplicationsQuality of LifeRenal DialysisTissue DonorsTissue and Organ ProcurementTreatment OutcomeUtilization ReviewWaiting ListsYoung Adult